Blood-Derived CD4 T Cells Naturally Resist Pyroptosis during Abortive HIV-1 Infection  by Muñoz-Arias, Isa et al.
Short Article
Blood-Derived CD4 T Cells Naturally Resist
Pyroptosis during Abortive HIV-1 InfectionGraphical AbstractHighlightsd Lymphoid-derived CD4 T cells undergo IFI16-driven
pyroptosis after abortive HIV infection
d Blood CD4 T cells resist pyroptosis due to a deeper resting
state with lower IFI16 levels
d Blood CD4 T cells become sensitized for pyroptosis by co-
culture with lymphoid cells
d Re-isolation of blood CD4 T cells from co-cultures restores
their resistant stateMun˜oz-Arias et al., 2015, Cell Host & Microbe 18, 463–470
October 14, 2015 ª2015 Elsevier Inc.
http://dx.doi.org/10.1016/j.chom.2015.09.010Authors
Isa Mun˜oz-Arias, Gilad Doitsh, Zhiyuan
Yang, Stefanie Sowinski, Debbie
Ruelas, Warner C. Greene
Correspondence
wgreene@gladstone.ucsf.edu
In Brief
HIV causes CD4 T cell depletion, mostly
driven by pyroptosis of abortively
infected cells. Mun˜oz-Arias et al.
demonstrate that blood-derived CD4 T
cells are resistant to HIV-mediated
pyroptosis. However, interactions with
lymphoid tissue-derived cells sensitize
these cells to pyroptosis, indicating how
trafficking and interactions within
lymphoid tissues shape responses to
HIV.
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Progression to AIDS is driven byCD4 T cell depletion,
mostly involving pyroptosis elicited by abortive HIV
infection of CD4 T cells in lymphoid tissues. Ineffi-
cient reverse transcription in these cells leads to
cytoplasmic accumulation of viral DNAs that are
detected by the DNA sensor IFI16, resulting in in-
flammasome assembly, caspase-1 activation, and
pyroptosis. Unexpectedly, we found that peripheral
blood-derived CD4 T cells naturally resist pyroptosis.
This resistance is partly due to their deeper resting
state, resulting in fewer HIV-1 reverse transcripts
and lower IFI16 expression. However, when co-
cultured with lymphoid-derived cells, blood-derived
CD4 T cells become sensitized to pyroptosis, likely
recapitulating interactions occurring within lymphoid
tissues. Sensitization correlates with higher levels
of activated NF-kB, IFI16 expression, and reverse
transcription. Blood-derived lymphocytes purified
from co-cultures lose sensitivity to pyroptosis. These
differences highlight how the lymphoid tissue micro-
environment encountered by trafficking CD4 T lym-
phocytes dynamically shapes their biological res-
ponse to HIV.
INTRODUCTION
Abortive HIV infection is a key driver of ‘‘bystander’’ CD4 T cell
depletion in lymphoid tissues. Recent studies indicate that HIV
fuses normally to these quiescent cells; however, because of
their resting state, the elongation step of reverse transcription
is inefficient, and consequently, short HIV DNA transcripts
accumulate in the cytosol (Doitsh et al., 2010). The DNA sensor
IFI16 detects these viral DNAs and triggers an innate inter-
feron-b response and inflammasome assembly that leads to
caspase-1 activation (Doitsh et al., 2010, 2014; Gariano et al.,
2012; Kerur et al., 2011; Monroe et al., 2014; Schroder and
Tschopp, 2010; Steele et al., 2014; Unterholzner et al., 2010).
Activated caspase-1 induces pyroptosis, a highly inflammatory
form of programmed cell death associated with pro-inter-
leukin-1b processing, plasma membrane pore formation, andCell Hostextrusion of cytoplasmic contents (Doitsh et al., 2014; Fink and
Cookson, 2005; Lamkanfi and Dixit, 2010; Miao et al., 2011).
While resting CD4 T cells derived from tonsil, spleen, and gut-
associated lymphatic tissue (GALT) infected with X4- or R5-
tropic HIV undergo pyroptosis (Steele et al., 2014), it is not known
whether blood-derived CD4 T cells are similarly susceptible to
this pathway of programmed cell death. Since naive CD4
T cells often reside in lymphoid tissues for 12–18 hr before re-
turning to peripheral blood (Cyster, 2005), we investigated the
possibility that differences in the microenvironments found in
these two tissues might affect the sensitivity of CD4 T cells to
pyroptosis mediated by abortive HIV infection.RESULTS
Blood-Derived CD4 T Cells Are Naturally Resistant to
HIV-Mediated Depletion
The sensitivity of blood- and lymphoid tissue-derived CD4 T cells
to HIV-mediated depletion was assessed in the human lymphoid
aggregated culture (HLAC) system (Figure 1A) (Doitsh et al.,
2010; Jekle et al., 2003). Effector tonsil cells were infected with
the lab-adapted CXCR4-tropic virus NL4-3. As expected, car-
boxyfluoroscein diacetate succinimydyl ester (CFSE)-labeled
(target) tonsil CD4 T cells were massively depleted when co-
cultured with productively infected effector tonsil cells (Fig-
ure 1B). In agreement with prior results, CD4 T cell depletion
persisted in the presence of azidothymidine (AZT), a nucleoside
reverse transcriptase inhibitor that allows the accumulation of
short reverse transcripts but blocks the generation of full-
length late transcripts though chain termination. These findings
with AZT indicate that the observed cell death was not a con-
sequence of productive infection. However, cell death was
blocked by efavirenz (EFV), a nonnucleoside reverse transcrip-
tase inhibitor that allosterically inhibits reverse transcriptase,
thereby preventing accumulation of the short viral DNA tran-
scripts (Figure 1B) (Doitsh et al., 2010; Quan et al., 1999). This
pattern of drug sensitivity where EFV but not AZT blocks cell
death is characteristic of pyroptosis triggered by abortive HIV
infection and is consistent with prior studies (Doitsh et al., 2010).
To determine if resting blood-derived CD4 T cells are suscep-
tible to this mechanism of HIV-induced cell death, effector
peripheral blood lymphocytes (PBLs) were stimulated with phy-
tohemagglutin (PHA) and interleukin-2 (IL-2) for 48 hr to render
them susceptible to productive HIV infection. Effector PBLs& Microbe 18, 463–470, October 14, 2015 ª2015 Elsevier Inc. 463
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Figure 1. Blood-Derived CD4 T Cells
Are Naturally Resistant to HIV-Mediated
Depletion
(A) The HLAC system. Uninfected cells were
labeled with CFSE (target cells) and treated with
medium, azidothymidine (AZT), or AZT and efavir-
enz (EFV), and then co-cultured with NL4-3 pro-
ductively infected (effector) cells for 5 days. Cells
were harvested and analyzed by flow cytometry.
(B) Percent viable target tonsil CD4 T cells co-
cultured with infected tonsil cells.
(C) Percent viable target blood CD4 T cells co-
cultured with infected PBLs.
(D) Percent viable target tonsil CD4 T cells co-
cultured with infected PBLs.
(E) Virion-based fusion assays were performed
with BLAM-Vpr-NL4-3-infected tonsil lymphocytes
or PBLs. Cells were then loaded with the CCF2-AM
dye. Gated populations represent the percentage
of fused CD4 T cells scoring positive for BLAM-
dependent CCF2-AM cleavage. Data presented in
(B)–(D) reflect cumulative results from three ex-
periments; data in (E) are representative of a single
experiment performed three times with similar re-
sults. Error bars, SEM. See also Figure S1.were co-cultured with resting target PBLs 5 days after infection
(Figure 1A). Strikingly, resting target blood CD4 T cells were
not depleted (Figure 1C), even though these same effector cells
readily induced target tonsil CD4 T cell depletion (Figure 1D).
These results imply that the resistance of target PBLs to deple-
tion is not due to inefficient viral production or transfer from
effector PBLs.
Since HIV-infected subjects exhibit higher levels of overall
immune activation compared to healthy subjects even when
their viral load is controlled by effective combination antiretrovi-
ral therapy (cART) (Lederman et al., 2013), we explored whether
higher levels of caspase-1 activation might be present in HIV-
infected patient blood samples. Caspase-1 activation was
monitored in CD4 T cells from the blood of 11 healthy and 15
HIV-infected (8 untreated and 7 cART-treated) donors by stain-
ing with cell-permeable fluorogenic caspase-1-specific sub-
strates (CaspLux-1) followed by flow cytometric analyses. In all
cases, less than 1% of patient blood-derived CD4 T cells scored
positive for caspase-1 activation (see Figure S1A available on-
line). Lysates from HIV-infected donors and healthy monocytes
were also compared by immunoblotting with anti-caspase-1 an-
tibodies to identify the inactive proenzyme (p50) and the active464 Cell Host & Microbe 18, 463–470, October 14, 2015 ª2015 Elsevier Inc.(p20 and p10) subunits that form during
capase-1 activation (Figure S1B). None
of the HIV-infected donors showed evi-
dence of activated caspase-1, whereas
the p10 and p20 subunits were readily de-
tected in monocytes, where caspase-1 is
constitutively active. Thus, the vast major-
ity of blood-derived CD4 T cells from HIV-
infected subjects, on and off cART, do not
exhibit caspase-1 activation.
Next, we assessed the level of HIV
fusion to blood- and lymphoid tissue-derived CD4 T cells. Using a virion-based fusion assay (Cavrois
et al., 2002), we found that NL4-3 fused similarly to CD4
T cells from both tissues and fusion was effectively inhibited
by addition of the CXCR4 coreceptor antagonist, AMD3100
(Figure 1E). Thus, differences in viral entry into target blood
CD4 T cells (versus tonsil cells) do not explain their resistance
to pyroptosis.
Blood-Derived CD4 T Cells Accumulate Fewer Reverse
Transcripts and Express Less IFI16 Than Lymphoid
Tissue-Derived CD4 T Cells
To further dissect the basis for the resistance of blood-derived
CD4 T cells to HIV-mediated depletion, we used a flexible ex-
perimental system where HEK293T cells are transfected with
the viral plasmid pNLENG1I and then overlaid with blood- or
tonsil-derived cells (Figure 2A) (Doitsh et al., 2014; Levy et al.,
2004). In this system, tonsil-derived CD4 T cells were massively
depleted. Efavirenz prevented depletion of these cells, con-
firming that the depletion requires steps of the viral life cycle
beyond gp120 engagement and reverse transcription initia-
tion. Conversely, overlaid blood-derived CD4 T cells remained
resistant to depletion (Figure 2B). As shown by qPCR analysis,
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Figure 2. Blood-Derived CD4 T Cells Accumulate Fewer Reverse Transcripts and Express Less IFI16 DNA Sensor than Tonsil CD4 T Cells
(A) The HEK293T overlay culture system. Lymphocytes were overlaid on NLENG1I-transfected HEK293T cells for 5–48 hr. Samples were then immunostained
and analyzed by flow cytometry, or lysed for DNA or mRNA purification and analyzed by qPCR or RT-qPCR.
(B) Percentages of viable tonsil- or blood-derived CD4 T cells 48 hr after overlay.
(C and D) Fold increase in HIV DNA versus the corresponding uninfected lymphocytes 5 hr after overlay. (C) Envelope or (D) Gag HIV DNA.
(E) Virus-producing HEK293T cells were overlaid with dNs-treated PBLs for 5 hr. Shown is the fold increase in HIV Envelope DNA versus the infected untreated
PBLs.
(F) Percentages of viable CD4 T cells 48 hr after overlay on virus-producing HEK293T.
(G) Fold increase in IFI16 mRNA in purified CD4 T cells from three tonsil versus three blood donors.
(H) Immunoblot of IFI16 expression in resting blood- or tonsil-purified CD4 T cells. IFI16 expression varied among different cellular compartments (25%–99% less
IFI16 in blood than tonsil CD4 T cells). Tonsil- and blood-purified CD4 T samples were analyzed on the same gel exposed for the same length of time, but are
shown separately for graphical clarity.
(I and J) Fold increase in type I interferon mRNA versus corresponding uninfected lymphocytes 24 hr after overlay on virus-producing HEK293T cells (I) inter-
feron-b or (J) interferon-amRNA. Data shown in (B), (F), and (G) represent cumulative results from at least three experiments; representative results from a single
experiment repeated three times with similar results are shown in (C)–(E) and (H)–(J). Error bars, SEM.5 hr after overlay on NLENG1I-transfected HEK293T cells,
tonsil lymphocytes generated 3- to 10-fold more HIV reverse
transcripts than PBLs (Figures 2C and 2D), suggesting
that the accumulation of fewer HIV reverse transcripts may
explain the resistance of blood CD4 T cells to HIV-mediated
depletion.
To determine if boosting HIV reverse transcription was suffi-
cient to induce blood CD4 T cell depletion, we treated PBLs
with deoxynucleosides (dNs, 2.5–5 mM), for 0–1 hr before over-Cell Hostlaying them on virus-producing HEK293T cells (Plesa et al.,
2007; Zack et al., 1990). Overlaid dNs-treated PBLs produced
up to 40-fold more HIV Envelope DNA than their untreated coun-
terparts (Figure 2E). However, the dNs-dependent increase in
reverse transcription was not sufficient to sensitize blood-
derived CD4 T cells to depletion (Figure 2F). These data suggest
that restriction of reverse transcription is not the only factor un-
derlying the intrinsic resistance of blood-derived CD4 T cells to
HIV-mediated depletion.& Microbe 18, 463–470, October 14, 2015 ª2015 Elsevier Inc. 465
Figure 3. Blood-Derived CD4 T Cells Co-Cultured with Lymphoid Tissue-Derived Cells Are Susceptible to HIV-Mediated Depletion
(A) Percent viable target CD4 T cells 48 hr after overlay on pNLENG1I-transfected HEK293T cells. The data presented for isolated cultures of tonsil or blood cells
are the same as presented in Figure 2B, which corresponded to a portion of the larger experiment shown here.
(B) Percent viable blood CD4 T cells after 48 hr of co-culture with different percentages of CMAC+ tonsil cells and overlay on virus-producing HEK293T cells.
(C) Percent viable blood CD4 T cells 48 hr after overlay on virus-producing HEK293T in direct contact (left panel) with or separated by a transwell insert (right
panel) from CMAC+ tonsil cells.
(D) Percent viable target-CD4 T cells 48 hr after overlay on D116N-NLENG1I-transfected HEK293T.
(E) Percent viable blood CD4 T cells after 48 hr of co-culture with enriched CMAC+ tonsil-derived B cells, CD8 T cells, or CD4 T cells and overlay on virus-
producing HEK293T cells. Data shown in (A)–(E) represent cumulative results from at least three experiments. Error bars, SEM. See also Figure S2.Next, we compared expression levels of the DNA sensor IFI16,
in blood- and lymphoid tissue-derived CD4 T cells. IFI16 tran-
scription was approximately 3-fold higher in tonsil than blood-
derived CD4 T cells (Figure 2G); the reduction in IFI16 protein
expression was even greater (Figure 2H). With insufficient IFI16
expression, HIV reverse transcripts would not be sensed, and
caspase-1 would not be activated to induce pyroptotic cell
death.
IFI16 also induces the type I interferon response upon DNA
sensing (Unterholzner et al., 2010). Blood-derived CD4 T cells
produced less type I interferon mRNA than their tonsil counter-
parts, 24 hr after overlay on virus-producing HEK293T cells
(Figures 2I and 2J). These findings suggest that lower reverse
transcription coupled with lower IFI16 expression results in
less HIV DNA sensing. Of note, Berg et al. reported that human
primary T cells fail to induce strong type I interferon responses
and concluded that the defect involves impaired DNA sensing
machinery (Berg et al., 2014). While these findings raise the
possibility that diminished reverse transcription and decreased
IFI16 expression contribute to the overall resistance of blood-
derived CD4 T cells to pyroptosis, they do not exclude the
possible involvement of additional, yet-unidentified intracel-
lular blocks.466 Cell Host & Microbe 18, 463–470, October 14, 2015 ª2015 ElsevBlood-Derived CD4 T Cells Co-Cultured with Lymphoid
Tissue-Derived Cells Are Susceptible to HIV-Mediated
Depletion
The microenvironments of lymphoid tissues and peripheral
blood are quite distinct (Cyster, 2005; Eckstein et al., 2001;
Kreisberg et al., 2006; Moutsopoulos et al., 2006). To test
if the lymphoid tissue microenvironment is necessary and
sufficient to induce abortive HIV infection-mediated depletion
of CD4 T cells, we mimicked this environment by coculturing
PBLs with tonsil-derived cells using the HLAC and HEK293T
overlay culture systems. Remarkably, blood-derived CD4
T cells were rendered sensitive to depletion when co-cultured
with tonsil cells (Figures 3A and S2A). This effect was not
the result of allogenic cellular activation alone, as co-culture
of PBLs from mismatched donors was not sufficient to
sensitize target blood-derived CD4 T cells for depletion (Fig-
ure S2B). Thus, blood CD4 T cells are highly resistant to pyrop-
tosis unless co-cultured with tonsil cells, raising the possibility
that the lymphoid microenvironment sensitizes CD4 T cells
abortive HIV-mediated depletion. Interestingly, the percent
depletion of blood CD4 T cells increased with the fraction of
tonsil lymphocytes (Figure 3B). Splenocytes also sensitized
blood CD4 T cells to HIV-mediated depletion, suggestingier Inc.
that this phenotype is a general property of lymphoid tissues
(Figure S2C).
To determine if sensitization of blood CD4 T cells requires
close cell-to-cell interactions, PBLs were allowed to interact
directly with virus-producing HEK293T cells and 7-amino-4-
chloromethylcoumarin (CMAC)-labeled tonsil cells, or were
separated from tonsil cells by a transwell insert. When separated
from tonsil cells, blood CD4 T cells were resistant to depletion
(Figures 3C and S2D), suggesting that close interactions be-
tween lymphoid- and blood-derived cells are required for sen-
sitization. These results are consistent with our finding that
supernatants from tonsil cultures do not render blood CD4
T cells susceptible to pyroptosis (data not shown). However,
these findings do not exclude the possibility that cell-to-cell
signaling induces expression of soluble factor(s) that in turn me-
diates sensitization.
We recently found that cell-to-cell spread of HIV-1 is required
for pyroptosis of lymphoid-derived CD4 T cells (Galloway et al.,
2015). If blood-derived CD4 T cell depletion requires direct deliv-
ery of virions from productively infected lymphoid tissue-derived
CD4 T cells, the transwell system could have interrupted this
infection pathway. To investigate this possibility, HEK293T cells
were transfected with an integrase-defective viral plasmid,
NLENG1I-D116N (Gelderblom et al., 2008). Thus, transfected
HEK293T cells produce virions that fuse to but do not integrate
into target lymphocytes. When overlaid on NLENG1I-D116N-
transfected HEK293T cells, tonsil CD4 T cells were effectively
depleted. These findings confirm that viral integration and pro-
ductive infection are not required for lymphoid tissue-derived
CD4 T cell depletion (Doitsh et al., 2010). When the same condi-
tions were replicated with PBLs, blood CD4 T cells were not
depleted unless they were co-cultured with tonsil cells (Fig-
ure 3D). Thus, although the virus need not emanate from
lymphoid tissue-derived CD4 T cells, close interactions between
tonsil and blood cells are required for sensitization to HIV-medi-
ated depletion (Figures 3C, 3D, and S2C).
Next, we investigated whether the sensitization of blood cells
reflects a specific property of CD4 T cells in lymphoid tissue.
Tonsil CD4 T, CD8 T, and B cells were enriched with MACS Mil-
tenyi beads (Figure S2E). Interestingly, all three enriched popula-
tions equally sensitized blood-derived CD4 T cells to depletion
(Figure 3E). Thus, the ability to sensitize is not limited to lymphoid
tissue-derived CD4 T cells. Since B cells and CD8 T cells are not
susceptible to HIV infection or depletion, these results further
exclude the possibility that sensitization requires productive
infection or death of lymphoid-derived CD4 T cells. Additionally,
these findings further confirm that sensitization of blood CD4
T cells does not require the virus to emanate from lymphoid
tissue-derived CD4 T cells.
Co-Culture with Lymphoid Tissue-Derived Cells
Sensitizes Blood CD4 T Cells to Pyroptosis Induced by
Multiple Inflammasomes
Although abortive HIV infection of lymphoid tissue-derived CD4
T cells leads to caspase-1-dependent pyroptosis, it was impor-
tant to determine if sensitized blood CD4 T cells die by the same
mechanism or another pathway of programmed cell death, such
as apoptosis or necroptosis (Fink and Cookson, 2005; Miao
et al., 2011). To test this, NLENG1I-transfected HEK293T cellsCell Hostwere overlaid with co-cultured tonsil lymphocytes and PBLs in
the presence of a pancaspase, caspase-1, or caspase-3 inhibi-
tor. The death of co-cultured blood-derived CD4 T cells was effi-
ciently prevented by the caspase-1 and pancaspase inhibitors,
but not by the caspase-3 inhibitor (Figure 4A), implying that cas-
pase-1 activation is essential for the death of these cells.
Next, we analyzed CD4 T cells from tonsil, PBLs, or co-
cultures of those cells for activated caspase-1 and propidium
iodide (PI) uptake after 48 hr of overlay on virus-producing
HEK293T cells (Figure S3A). After HIV infection, only a very small
percentage of blood CD4 T cells stained positive for caspase-1
activation and PI uptake. Conversely, co-culture with tonsil cells
induced a 4- to 5-fold increase in the percentage of blood CD4
T cells that stained positive for caspase-1 activation and a 5-
to 6-fold increase for PI uptake. In addition, co-culture with tonsil
cells induced a 3-fold increase in the percentage of blood CD4
T cells that took up ethidium bromide (EtBr), presumably through
membrane pores formed during pyroptosis, while none of the
samples took up ethidium homodimer-2 (EtD2) (Figure S3B). Up-
take of EtBr coupled with exclusion of EthD2 is characteristic of
pyroptosis (Fink and Cookson, 2006). These results further sug-
gest co-cultured blood- and tonsil-derived CD4 T cells undergo
pyroptosis after abortive HIV infection.
Next, we examined whether co-culture with lymphoid cells al-
ters the activation state of blood-derived CD4 T cells. As shown
by immunostaining for CD69, CD25, and HLA-DR, cellular acti-
vation was greater in tonsil- versus blood-derived CD4 T cells.
However, expression of these same activation markers was
not increased in the majority of co-cultured blood CD4 T cells
(Figure S3C).
To test for more subtle changes in activation, PBLs were
stained intracellularly with antibodies specific for the RelA (p65)
subunit of NF-kB phosphorylated at Ser-536. This site-specific
phosphorylation only occurs after stimulus-coupled degradation
of IkBa (Chen and Greene, 2004; Huang et al., 2010). In blood
CD4 T cells co-cultured with tonsil lymphocytes, Ser-536 phos-
phorylation of RelA was significantly increased by 2-fold com-
pared to blood CD4 T cells cultured alone (Figure 4B).
To test if this level of RelA-Ser-536 phosphorylation was
functionally significant, tonsil lymphocytes, PBLs, or co-cultures
of those cells were treated with nigericin (10 or 20 mM for 3 hr)
(Figure S3D). Nigericin is a potent inducer of pyroptosis involving
assembly of theNF-kB-inducible gene, NLRP3, and other inflam-
masomecomponents (Qiao et al., 2012). Under these conditions,
higher percentages of tonsil- and co-cultured blood-derivedCD4
T cells displayed caspase-1 activation and PI uptake, and
became susceptible to depletion versus PBLs cultured alone
(Figures S3D and 4C). These results imply that CD4 T cells circu-
lating in the blood are resistant to pyroptosis elicited either by
abortive HIV infection or nigericin exposure. The low level of
NF-kB activation occurring in co-cultured blood CD4 T cells is
likely important for sensitization, as this factor can regulate
expression of key inflammasome components. Finally, reverse
transcription (Figure S3E) and expression of IFI16 (Figure 4B)
were increased 3- and 2-fold, respectively, in co-cultured blood
CD4Tcells. The increase in reverse transcription and the upregu-
lation of IFI16 are likely required for induction of pyroptosis.
The frequent trafficking of naive CD4 T cells between blood
and lymphoid tissues suggests that the gain and loss of& Microbe 18, 463–470, October 14, 2015 ª2015 Elsevier Inc. 467
Figure 4. Co-Culture with Lymphoid Tissue-Derived Cells Sensitizes Blood CD4 T Cells to Pyroptosis Induced by Multiple Inflammasomes
(A) Co-cultured PBLs were treated with medium, or inhibitors of caspase-1, caspase-3, or a pancaspase inhibitor, and then overlaid on NLENG1I-transfected
HEK293T for 48 hr. Of note, the caspase-1 inhibitor also weakly inhibits caspase-4 and -5. Shown is the percentage of viable blood-derived CD4 T cells in the
presence of these different inhibitors.
(B) PBLs were co-cultured with CMAC+ tonsil cells for 48 hr and stained intracellularly for P-Ser536 RelA or IFI16. Shown is the fold increase median fluorescence
intensity (MFI) for each protein in co-cultured PBLs versus PBLs cultured alone.
(C) Percent viable CD4 T cells 6 hr after nigericin treatment (20 mM).
(D) PBLs cultured alone, co-cultured with tonsil cells, or sorted from tonsil co-cultures were overlaid on pNLENG1I-transfected HEK293T cells for 48 hr. Shown is
the percentage of viable bloodCD4 T cells. Cumulative results from (A, C, and D) three or (B) four experiments are presented. Error bars, SEM. See also Figure S3.
(E) Blood-trafficking CD4 T cells are resistant to HIV-mediated pyroptosis at least in part as a result of less reverse transcription and lower IFI16 expression. When
these cells return to the lymphoid tissues, cell-cell interactions sensitize them to this mechanism of HIV-induced depletion.sensitivity to pyroptosis may be quite dynamic. To test for poten-
tial lability of sensitization, blood-derived CD4 T cells were
sorted from co-cultures and analyzed for IFI16 transcription by
RT-qPCR. These sorted blood CD4 T cells transcribed less
IFI16 than tonsil-derived CD4 T cells (Figure S3F). Remarkably,
sorted PBLs that were overlaid on pNLENG1I-transfected
HEK293T cells for 48 hr reacquired resistance to pyroptosis (Fig-
ure 4D). These results imply that the sensitization of CD4 T cells
to HIV-mediated pyroptosis requires continuous signaling and is
rapidly lost when this signaling is interrupted, as would occur
when CD4 T cells in lymphoid tissues return to the bloodstream
(Figure 4E).
DISCUSSION
Our studies reveal that blood-derived CD4 T cells are naturally
resistant to abortive HIV infection-mediated pyroptosis, a finding468 Cell Host & Microbe 18, 463–470, October 14, 2015 ª2015 Elsevthat stands in sharp contrast to the sensitivity of CD4 T cells
residing in lymphoid tissues. This intrinsic resistance of blood
CD4 T cells may be explained by decreased reverse transcrip-
tion and IFI16 sensor expression needed to induce pyroptosis,
but other unidentified factors may also contribute. These find-
ings underscore a fundamental biological difference between
CD4 T cells circulating in the blood versus cells within lymphoid
tissues. Had we initiated our studies with blood-derived CD4
T cells, we would have not detected the pyroptotic cell death
pathway of abortively HIV-infected cells, which promotes a
massive CD4 T cell depletion during HIV infection in lymphoid tis-
sues (Doitsh et al., 2010; Doitsh et al., 2014).
Our findings illustrate how the state of cellular activation,
which is influenced by the tissue microenvironment, critically de-
termines how CD4 T cells die during HIV infection (Kreisberg
et al., 2006; Moutsopoulos et al., 2006). For example, many
CD4 T cells in the lamina propria of GALT exhibit a high activationier Inc.
state that allows productive HIV infection culminating in death by
apoptosis (Brenchley et al., 2004; Li et al., 2005; Mattapallil et al.,
2005). Conversely, although ‘‘primed,’’ more than 95% of CD4
T cells derived from spleen, lymph node, and tonsil are too quies-
cent to support productive infection (Kreisberg et al., 2006;
Moutsopoulos et al., 2006). However, these cells are activated
sufficiently to support an abortive form of infection culminating
in caspase-1-dependent pyroptosis. Most CD4 T cells in the
blood, however, are in a deeper resting state (Moutsopoulos
et al., 2006; Zack et al., 1990) than those residing in lymphoid tis-
sues and are therefore naturally resistant to both productive
infection and pyroptosis. Although blood CD4 T cells from HIV-
infected subjects have been reported to exhibit a higher state
of activation, fewer than 1% of these cells displayed caspase-
1activation. The natural resistance of blood CD4 T cells to pyrop-
tosis may benefit the host by confining the intense inflammation
associated with abortive HIV infection to lymphoid tissues.
These results further underscore AIDS as a disease of lymphoid
tissues, not blood.
Strikingly, co-culture with lymphoid tissue-derived cells sensi-
tizes blood CD4 T cells to pyroptosis. This sensitization is rapidly
lost when the co-cultures are disassembled. Since CD4 T cells
traffic in and out of lymphoid tissues, they likely rapidly gain
and lose sensitivity to pyroptosis (Figure 4D). Our findings sug-
gest that key signals sensitizing cells to pyroptosis are depen-
dent on cell-to-cell interactions and that such interactions may
extend to other inducers of pyroptosis such as nigericin which
involves assembly of a different inflammasome, NLRP3 (Fig-
ure S3D). With a better understanding of these yet-unidentified
signaling events, it might be possible to block signal transduc-
tion, thereby conferring upon lymphoid-CD4 T cells the same
resistance to pyroptosis that is naturally present in circulating
blood CD4 T cells. This could potentially result in a host-directed
approach to control progression of HIV disease to AIDS that
could be combined with cART or potentially used in cases of
multidrug resistance where cART options are limited.
EXPERIMENTAL PROCEDURES
Statistical Analysis
To exclude other causes of cell death not involving HIV infection, we normal-
ized CD4 T cell absolute counts to that of CD8 T cells, which do not undergo
pyroptosis in the presence of HIV. Since ratios do not follow a normal distribu-
tion, we used a log-transformation on the CD4/CD8 ratios to uninfected
controls. The assumption of normality of the log-transformed values was
examined with the Shapiro-Wilk test. One-sample t test and t-confidence in-
tervals were used for normally distributed data. A one-sample Wilcoxon
rank-sum test was used to calculate the p value of nonnormally distributed
data. In all experiments involving infected tonsil, PBLs, or co-cultured tonsil
and PBLs, CD4 T cell depletion was significantly higher than in the correspond-
ing uninfected control (p < 0.05), while depletion of blood CD4 T cells cultured
alone was not significant (p > 0.05).
Preparation of Viral Stocks
To generate viral stocks, HEK293T cells (ATCC) were transfected with pNL4-3
(NIH AIDS Reagent Program) (80 mg/T175 flask) using the calcium-phosphate
method. Please see our Supplemental Experimental Procedures for detailed
experimental protocols.
Fusion Assay
Tonsil cells or PBLswere infectedwith NL4-3 BLAM-Vpr virus (50 ng/ml) for 1 hr
at 37C. Cells were washed with CO2-independent medium, stained withCell HostCCF2-AM for 1 hr at room temperature, and incubated overnight in probene-
cid/CO2-independent medium at room temperature as described (Cavrois
et al., 2002). The next day, cells were stained for surface CD4 expression
and fixed with 2%–4% paraformaldehyde for at least 1 hr before measurement
of cell fusion indicated by BLAM cleavage of CCF2-AM.
qPCR
Lymphocytes were treated with EFV or left untreated and overlaid on DNase
I-treated pNLENG1I-transfected HEK293T. The cells were harvested 5 hr later,
andDNAwas purifiedwith theQIAGENDNeasy Blood and Tissue Kit. A b-actin
probe was used as an internal reference. Corresponding uninfected controls
served as the calibrator to calculateDDCT values. The probes for HIV envelope
and Gag have been described (Doitsh et al., 2010). Please see Supplemental
Experimental Procedures for detailed experimental protocols.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and Supplemental Experi-
mental Procedures and can be found with this article at http://dx.doi.org/10.
1016/j.chom.2015.09.010.
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